Bacillus subtilis Maseca-1 Antimicrobial Peptides for Food Preservation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current research on antimicrobial peptides has limitations in finding effective therapeutic agents against pathogenic Gram-positive bacteria and fungi, and there is a need for novel probiotic strains that can enhance gastrointestinal health and inhibit pathogens without causing adverse effects.
Innovation Solution
Isolation and characterization of a novel spore-forming Bacillus subtilis Maseca-1 strain from nixtamalized whole corn, which produces lantibiotic peptides and exopolysaccharides with antimicrobial properties, capable of inhibiting pathogens and promoting gut health.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antimicrobial peptides are used, then some pathogenic bacteria can be inhibited, but they lack effectiveness against pathogenic Gram-positive bacteria and fungi
Solution Approach 1:
The Bacillus subtilis Maseca-1 strain produces multiple types of antimicrobial compounds including lantibiotics (such as nisin), surfactin, and other lipopeptides that work synergistically to provide broad-spectrum activity against Gram-positive bacteria, Gram-negative bacteria, and fungi, resolving the limitation of conventional single-type antimicrobial peptides
2Reliability
If antibiotics are used to control infectious diseases, then disease rates decrease, but allergies and autoimmune disorders increase
Solution Approach 1:
The patent utilizes the natural antimicrobial compounds produced by Bacillus subtilis Maseca-1 to control pathogens, converting the potential harm of antibiotic resistance and side effects into a beneficial natural alternative that maintains immune system function and reduces allergic responses while effectively controlling infectious diseases
3Adaptability or versatility
If probiotic microbes are introduced to enhance gut health, then microbiota balance improves, but colonization capability against established pathogens must be sufficient
Solution Approach 1:
The Bacillus subtilis Maseca-1 strain combines probiotic functions (producing short-chain fatty acids, enhancing gut barrier function) with potent pathogen inhibition capabilities (producing lantibiotics and surfactin), merging the benefits of gut health promotion with reliable pathogen control in a single organism
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Bacillus subtilis Maseca-1 effectively inhibits the growth of pathogens like Micrococcus luteus, Bacillus cereus, and Aspergillus flavus, and promotes gut health by colonizing the gastrointestinal tract, producing short-chain fatty acids and antimicrobial compounds, thereby enhancing the microbiota balance and extending food shelf-life.
Implementation Method 1
amphiphillic lipopeptides which are aggressive surface tension reducing agents, such as surfactin and the antifungal mycosubtilin. In these compounds, the lipo-substituent plays a key role in disrupting the cell membrane, while the amphiphilic component exhibits disruptive hemolytic properties.
Implementation Method 2
isolated biologically pure cultures of a novel spore forming Bacillus species, and more particularly, to Bacillus subtilis Maseca-1
Data Source
Figure 1
Figure 2A~2B
Figure 3A
AI summary
Biologically pure cultures of Bacillus subtilis were isolated from the pericarp of nixtamalized corn. The Bacillus microorganisms were characterized and found to produce novel peptides which have antimicrobial activity. The Bacillus microorganisms are active against Gram-positive bacteria and may be used as an agent to prevent spoilage in foods. The Bacillus microorganisms may be included in probiotic food compositions to help maintain healthy gastrointestinal flora and modulate animal digestion.